Cloning and porin activity of the major outer membrane protein P1 from Coxiella burnetii

Infection and Immunity

Volumn 70, Issue 12, 2002, Pages 6741-6750

  Varghees, Sunita ^a   Kiss, Kati ^a   Frans, Giovanni ^a   Braha, Orit ^a   Samuel, James E ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN P1; PORIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BETA SHEET; COXIELLA BURNETII; GRAM NEGATIVE BACTERIUM; INVERSE POLYMERASE CHAIN REACTION; LIPID BILAYER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CELL MEMBRANE; CLONING, MOLECULAR; COXIELLA BURNETII; GENE EXPRESSION REGULATION, BACTERIAL; LIPID BILAYERS; MEMBRANE PROTEINS; POLYMERASE CHAIN REACTION; PORINS; SEQUENCE ANALYSIS, DNA;

EID: 0036892866     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.12.6741-6750.2002     Document Type: Article

References (47)

1. Amano, K., and J. C. Williams. 1984. Sensitivity of Coxiella burnetii peptidoglycan to lysosome hydrolysis and correlation of sacculus rigidity with peptidoglycan-associated proteins. J. Bacteriol. 160:989-993.
2. Ascher, M. S., M. A. Berman, and R. Ruppanner. 1983. Initial clinical and immunologic evaluation of a new phase I Q fever vaccine and skin test in humans. J. Infect. Dis. 148:214-222.
3. Baca, O. G., and D. Paretsky. 1983. Q fever and Coxiella burnetii: A model for host-parasite interactions. Microbiol. Rev. 47:127-149.
4. Banerjee-Bhatnagar, N., C. R. Bolt, and J. C. Williams. 1996. Pore-forming activity of Coxiella burnetii outer membrane protein oligomer comprised of 29.5- and 31-kDa polypeptides. Ann. N. Y. Acad. Sci. 791:378-401.
5. Benz, R., R. E. W. Hancock, and T. Nakae. 1982. Outer membranes. In R. Antolini (ed.), Transport in Biomembranes: Model Systems and Reconstitution. Raven Press, New York, N.Y.
6. Brouqui, P. 1993. Chronic Q fever. Arch. Intern. Med. 153:642-648.
7. Heinzen, R. A., and T. Hackstadt. 1996. A developmental stage-specific histone H1 homolog of Coxiella burnetii. J. Bacteriol. 178:5049-5052.
8. Heinzen, R. A., T. Hackstadt, and J. E. Samuel. 1999. Developmental biology of Coxiella burnetii. Trends Microbiol. 7:149-154.
9. Heinzen, R. A., D. Howe, L. P. Mallavia, D. D. Rockey, and T. Hackstadt. 1996. Developmentally regulated synthesis of an unusually small, basic peptide by Coxiella burnetii. Mol. Microbiol. 22:9-19.
10. Hoffman, P., J. Seyer, and C. Butler. 1992. Molecular characterization of the 28- and 31-kilodalton subunits of the Legionella pneumophila major outer membrane protein. J. Bacteriol. 174:908-913.
11. Hoffman, P. S., M. Ripley, and W. Risini. 1992. Cloning and nucleotide sequence of a gene (ompS) encoding the major outer membrane protein of Legionella pneumophila. J. Bacteriol. 174:914-920.
12. Hoover, T. A., and J. C. Williams. 1990. A Coxiella burnetii gene encodes a 29-kD antigen with a bacterial lipoprotein signal sequence. Vaccines 90:447-450.
13. Kazar, J., R. Brezina, A. Palanova, B. Turda, and S. Schramek. 1982. Immunogenicity and reactogenicity of Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia. Bull. W. H. O. 60:389-394.
14. Kishimoto, R. A., J. W. Johnson, R. H. Kenyon, M. S. Ascher, E. W. Larson, and C. E. Pederson, Jr. 1978. Cell-mediated immune responses of guinea pigs to an inactivated phase I Coxiella burnetii vaccine. Infect. Immun. 19:194-198.
15. Koebnik, R., K. Locher, and P. Van Gelder. 2000. Structure and function of bacterial outer membrane proteins: Barrels in a nutshell. Mol. Microbiol. 37:239-253.
16. Labrenz, M., and P. Hirsch. The genus Coxiella. In G. Garrity, D. R. Boone, and R. W. Castenholz (ed.), Bergey's manual of systematic bacteriology, 2nd ed., in press. Springer-Verlag, New York, N.Y.
17. Lukacova, M., E. Gajdosova, L. Skultety, E. Kovacova, and J. Kazar. 1994. Characterization of protective effects of a 29 kDa protein isolated from Coxiella burnetii by detergent Empigen BB. Eur. J. Epidemiol. 10:227-230.
18. Mallavia, L. P. 1991. Genetics of rickettsiae. Eur. J. Epidemiol. 7:213-221.
19. Marmion, B. P., R. A. Ormsbee, M. Kyrkou, J. Wright, D. A. Worswick, A. A. Izzo, A. Esterman, B. Feery, and R. A. Shapiro. 1990. Vaccine prophylaxis of abattoir-associated Q fever: Eight years' experience in Australian abattoirs. Epidemiol. Infect. 104:275-287.
20. Maurin, M., and D. Raoult. 1996. Optimum treatment of intracellular infection. Drugs 2:45-55.
21. McCaul, T. F. 1991. The developmental cycle of Coxiella burnetii, p. 223-258. In J. C. Williams and H. A. Thompson (ed.), Q Fever: The Biology of Coxiella Burnetii. CRC Press, Boca Raton, Fla.
22. McCaul, T. F., N. Banerjee-Bhatnagar, and J. C. Williams. 1991. Antigenic differences between Coxiella burnetii cells revealed by postembedding immunoelectron microscopy and immunoblotting. Infect. Immun. 59:3243-3253.
23. McCaul, T. F., T. Hackstadt, and J. C. Williams. 1981. Ultrastructural and biological aspects of Coxiella burnetii under physical disruptions, p. 267. In W. Burgdorfer and R. L. Anacker (ed.), Rickettsiae and Rickettsial Diseases. Academic Press, New York, N.Y.
24. McCaul, T. F., and J. C. Williams. 1981. Developmental cycle of Coxiella burnetii: Structure and morphogenesis of vegetative and sporogenic differentiations. J. Bacteriol. 147:1063-1076.
25. Meiklejohn, G., and E. H. Lennette. 1950. Q fever in California. I. Observation on vaccine of human beings. Am. J. Hyg. 52:54-61.
26. Montal, M., and P. Mueller. 1972. Formation of bimolecular membranes from lipid bilayers and study of their electrical properties. Proc. Natl. Acad. Sci. USA 69:3561-3566.
27. Myers, W. F., O. G. Baca, and C. L. Wisseman. 1980. Genome size of the rickettsia Coxiella burnetii. J. Bacteriol. 144:460-461.
28. Raoult, D., and T. Marrie. 1995. Q fever. Clin. Infect. Dis. 20:489-496.
29. Samuel, J. E. 2000. Developmental cycle of Coxiella, p. 427-440. In Y. V. Brun and L. J. Shimkets (ed.), Prokaryotic Development. ASM Press, Washington, D.C.
30. Samuel, J. E., M. E. Frazier, and L. P. Mallavia. 1985. Correlation of plasmid type and disease caused by Coxiella burnetii. Infect. Immun. 49:775-779.
31. Schindler, H., and J. P. Rosenbusch. 1978. Matrix protein from Escherichia coli outer membranes forms voltage-controlled channels in lipid bilayers. Proc. Natl. Acad. Sci. USA 75:3751-3755.
32. Schirmer, T. 1998. General and specific porins from bacterial outer membranes. J. Struct. Biol. 121:101-109.
33. Schulz, G. E. 2000. β-barrel membrane proteins. Curr. Opin. Struct. Biol. 10:443-447.
34. Seshadri, R., L. R. Hendrix, and J. E. Samuel. 1999. Differential expression of translational elements by life cycle variants of Coxiella burnetii. Infect. Immun. 67:6026-6033.
35. Seshadri, R., and J. E. Samuel. 2001. Characterization of a stress-induced alternate sigma factor, RpoS, of Coxiella bumetii and its expression during the development cycle. Infect. Immun. 69:4874-4883.
36. Simonet, V., M. Mallea, D. Fourel, J.-M. Bolla, and J.-M. Pages. 1996. Crucial domains are conserved in Enterobacteriaceae porins. FEMS Microbiol. Lett. 136:91-97.
37. Smadel, J. E., M. J. Snyder, and F. C. Robbins. 1948. Vaccine against Q fever. Am. J. Hyg. 47:71-78.
38. Snyder, C. E., R. F. Wachter, and J. D. White. 1984. Identification of Coxiella burnetii antigens and attempts at envelope fractionation. Microbiology 1984:263-265.
39. Sugawara, E., and H. Nikaido. 1992. Pore-forming activity of OmpA protein of Escherichia coli. J. Biol. Chem. 267:2507-2511.
40. Todt, J., E. Rocque, and E. McGroarty. 1992. Effects of pH on bacterial porin function. Biochemistry 31:10471-10478.
41. Vivona, S., J. P. Lowenthal, S. Berman, A. S. Benenson, and J. E. Smadel. 1964. Report of a field story with Q fever vaccine. Am. J. Hyg. 79:143-153.
42. Waag, D. M., M. J. England, and M. L. M. Pitt. 1997. Comparative efficacy of a Coxiella burnetii chloroform: Methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol. Vaccine 15:1779-1783.
43. Wiebe, M. E., P. R. Burton, and D. M. Shankel. 1972. Isolation and characterization of two cell types of Coxiella burnetii. J. Bacteriol. 110:368-377.
44. Wilhelmsen, C. L., and D. M. Waag. 2000. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by Q fever vaccines. Comp. Med. 50:374-378.
45. Williams, J. C., M. R. Johnston, M. G. Peacock, L. A. Thomas, S. Stewart, and J. L. Portis. 1984. Monoclonal antibodies distinguish phase variants of Coxiella burnetii. Infect. Immun. 43:421-428.
46. Williams, J. C., T. A. Hoover, D. M. Waag, N. Banerjee-Bhatnagar, C. R. Bolt, and G. H. Scott. 1990. Vaccines against coxiellosis and Q fever. Ann. N. Y. Acad. Sci. 590:370-380.
47. Zhang, Q., J. C. Meitzler, S. Huang, and T. Morishita. 2000. Sequence polymorphism, predicted secondary structures, and surface-exposed conformational epitopes of Campylobacter major outer membrane protein. Infect. Immun. 68:5679-5689.